Role of Nrf2 in chronic liver disease

被引:188
|
作者
Tang, Wei [1 ]
Jiang, Yong-Fang [1 ]
Ponnusamy, Murugavel [2 ,3 ]
Diallo, Mamadou [4 ]
机构
[1] Cent S Univ, Xiangya Hosp 2, Liver Dis Res Ctr, Changsha 410011, Hunan, Peoples R China
[2] Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA
[3] Brown Univ, Alpert Med Sch, Providence, RI 02903 USA
[4] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
关键词
Nuclear erythroid 2-related factor 2; Chronic liver disease; Oxidative stress; Reactive oxygen species; Hepatic injury; Hepatic protection; HEPATITIS-B-VIRUS; ANTIOXIDANT RESPONSE ELEMENT; HIGH-FAT DIET; ACETAMINOPHEN-INDUCED HEPATOTOXICITY; DENSITY LIPOPROTEIN RECEPTOR; TRANSCRIPTION FACTOR NRF2; CELL-DEATH MECHANISMS; HUMAN HEPATOMA-CELLS; NF-KAPPA-B; OXIDATIVE STRESS;
D O I
10.3748/wjg.v20.i36.13079
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nuclear erythroid 2-related factor 2 (Nrf2) is a central regulator of antioxidative response elements-mediated gene expression. It has a significant role in adaptive responses to oxidative stress by interacting with the antioxidant response element, which induces the expression of a variety of downstream targets aimed at cytoprotection. Previous studies suggested oxidative stress and associated damage could represent a common link between different forms of diseases. Oxidative stress has been implicated in various liver diseases, including viral hepatitis, nonalcoholic fatty liver disease/steatohepatitis, alcoholic liver disease and drug-induced liver injury. Nrf2 activation is initiated by oxidative or electrophilic stress, and aids in the detoxification and elimination of potentially harmful exogenous chemicals and their metabolites. The expression of Nrf2 has been observed throughout human tissue, with high expression in detoxification organs, especially the liver. Thus, Nrf2 may serve as a major regulator of several cellular defense associated pathways by which hepatic cells combat oxidative stress. We review the relevant literature concerning the crucial role of Nrf2 and its signaling pathways against oxidative stress to protect hepatic cell from oxidative damage during development of common chronic liver diseases. We also review the use of Nrf2 as a therapeutic target to prevent and treat liver diseases. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
引用
收藏
页码:13079 / 13087
页数:9
相关论文
共 50 条
  • [31] Effect of Redox Modulating NRF2 Activators on Chronic Kidney Disease
    Choi, Bo-hyun
    Kang, Kyung-Shin
    Kwak, Mi-Kyoung
    MOLECULES, 2014, 19 (08): : 12727 - 12759
  • [32] Role of Nrf2 in Oxidative Stress, Neuroinflammation and Autophagy in Alzheimer's Disease: Regulation of Nrf2 by Different Signaling Pathways
    Kaur, Karamjeet
    Narang, Raj Kumar
    Singh, Shamsher
    CURRENT MOLECULAR MEDICINE, 2024,
  • [33] Role of Nrf2 in bone metabolism
    Sun, Yong-Xin
    Xu, Ai-Hua
    Yang, Yang
    Li, Jiliang
    JOURNAL OF BIOMEDICAL SCIENCE, 2015, 22
  • [34] Role of Nrf2 in bone metabolism
    Yong-Xin Sun
    Ai-Hua Xu
    Yang Yang
    Jiliang Li
    Journal of Biomedical Science, 22
  • [35] Role of Nrf2 in the pathogenesis of atherosclerosis
    Mimura, Junsei
    Itoh, Ken
    FREE RADICAL BIOLOGY AND MEDICINE, 2015, 88 : 221 - 232
  • [36] The Role of NRF2 in Mycobacterial Infection
    Matsuyama, Masashi
    Nonaka, Mizu
    Nakajima, Masayuki
    Morishima, Yuko
    Ishii, Yukio
    Hizawa, Nobuyuki
    ANTIOXIDANTS, 2021, 10 (12)
  • [37] Role of Nrf2 in rheumatoid arthritis
    Chadha, Swati
    Behl, Tapan
    Kumar, Arun
    Khullar, Gaurav
    Arora, Sandeep
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2020, 68 (04) : 171 - 181
  • [38] Role of NRF2 in Lung Cancer
    Sanchez-Ortega, Miriam
    Clara Carrera, Ana
    Garrido, Antonio
    CELLS, 2021, 10 (08)
  • [39] Role of NRF2 in Ovarian Cancer
    Tossetta, Giovanni
    Fantone, Sonia
    Montanari, Eva
    Marzioni, Daniela
    Goteri, Gaia
    ANTIOXIDANTS, 2022, 11 (04)
  • [40] The emerging role of Nrf2 in dermatotoxicology
    Tan, Nguan S.
    Wahli, Walter
    EMBO MOLECULAR MEDICINE, 2014, 6 (04) : 431 - 433